Bausch Health Companies Inc. issued the following announcement on June 4.
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for BAUSCH + LOMB INFUSE™ daily disposable silicone hydrogel (SiHy daily) contact lenses.
BAUSCH + LOMB INFUSE contact lenses feature a next generation contact lens material (kalifilcon A), which is designed to meet the unmet needs of contact lens wearers, including those who experience contact lens dryness. Engineered with Bausch + Lomb's most advanced proprietary contact lens technologies, BAUSCH + LOMB INFUSE offers outstanding breathability for healthy lens wear while providing exceptional all-day comfort and high definition optics.
"Bausch + Lomb continues to push the innovation curve in the contact lens space with the FDA's clearance of BAUSCH + LOMB INFUSE," said Joe Gordon, U.S. president, Bausch + Lomb. "We are excited to add this breakthrough new SiHy daily contact lens to our portfolio and provide the outstanding health, vision and comfort that practitioners expect and patients deserve from Bausch + Lomb. We anticipate BAUSCH + LOMB INFUSE will be available to eye care practitioners in the second half of 2020."
About Bausch + Lomb
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., is solely focused on helping people see. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries. For more information, visit www.bausch.com.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.
Original source can be found here.
